CD20 Protein (AA 141-188) (His-Avi Tag)
Quick Overview for CD20 Protein (AA 141-188) (His-Avi Tag) (ABIN7274102)
Target
See all CD20 (MS4A1) ProteinsProtein Type
Origin
Source
Purity
-
-
Protein Characteristics
- AA 141-188
-
Purification tag / Conjugate
- This CD20 protein is labelled with His-Avi Tag.
-
Purpose
- Human CD20/MS4A1 Protein
-
Sequence
- Ile141-Ser188
-
Characteristics
- Recombinant Human CD20/MS4A1 Protein is expressed from E.coli with His tag and Avi tag at the C-Terminus.It contains Ile141-Ser188.
-
Sterility
- 0.22 μm filtered
-
Endotoxin Level
- Less than 1EU per μg by the LAL method.
-
Biological Activity Comment
- Immobilized Human CD20, His Tag at 1μg/ml (100μl/well) on the plate. Dose response curve for Anti-CD20 Antibody, hFc Tag with the EC50 of 0.38μg/ml determined by ELISA. See testing image for detail.
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!ProductExpression SystemConjugateOriginPrice starts atExpression System HEK-293 CellsConjugate His tagOrigin HumanPrice starts at $16,231.82Expression System Cell-free protein synthesis (CFPS)Conjugate Strep TagOrigin HumanPrice starts at $18,117.43Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as 0.22μm filtered solution in 20 mM PB, 10 % Glycerol, 0.4M Urea, 1 mM GSH, 0.1 mM GSSG ( pH 7.0).
-
Storage
- -80 °C
-
Storage Comment
- Valid for 12 months from date of receipt when stored at -80°C., Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- CD20 (MS4A1) (Membrane-Spanning 4-Domains, Subfamily A, Member 1 (MS4A1))
-
Alternative Name
- CD20
-
Background
- B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R , CD117) and progressively increasing in concentration until maturity.CD20 is the target of the monoclonal antibodies rituximab, ocrelizumab, obinutuzumab, ofatumumab, ibritumomab tiuxetan, tositumomab, and ublituximab, which are all active agents in the treatment of all B cell lymphomas, leukemias, and B cell-mediated autoimmune diseases.
-
Molecular Weight
- 16.8 kDa same as Tris-Bis PAGE result.
-
UniProt
- P11836-1
Target
-